Lose some, win some

Get started

Contrave Vs. Wellbutrin: Drug Comparison

Compare common side effects, interactions, warnings, and more.

Medical Review byMike Bohl, MD, MBA, MPH, MS, ALMNov 4, 2024

Medication Name

Contrave

*image for illustrative purpose only

Wellbutrin SR

*image for illustrative purpose only

Contrave

*image for illustrative purpose only

Wellbutrin SR

*image for illustrative purpose only

Summary

Prescription only

Contrave® (naltrexone hydrochloride and bupropion hydrochloride) is a prescription medication used for weight management in adults, combining two active ingredients: naltrexone, which affects the brain's reward system, and bupropion, which influences appetite and cravings. It works by targeting the hypothalamus to reduce hunger and the mesolimbic reward system (a pathway in the brain that plays a key role in regulating feelings of pleasure, motivation, and reinforcement) to curb food cravings. Contrave is FDA-approved for chronic weight management. Common side effects include nausea, constipation, headache, and insomnia, while drug interactions can occur with MAO inhibitors, opioid pain medications, and drugs that lower the seizure threshold. Contrave carries a boxed warning for an increased risk of suicidal thoughts and behaviors, particularly in young adults, due to its bupropion component.

Prescription only

Wellbutrin SR® (bupropion sustained-release) is an antidepressant that works by inhibiting the reuptake of norepinephrine and dopamine in the brain, which helps improve mood and reduce symptoms of depression. Its FDA-approved indication includes the treatment of major depressive disorder (MDD). Off-label uses may include treating anxiety and attention-deficit hyperactivity disorder (ADHD). Wellbutrin SR is available in sustained-release tablet form. Common side effects include insomnia, dry mouth, constipation, and headache, and it has a boxed warning for an increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults.

Drug Category

Naltrexone: opioid antagonist

Bupropion: aminoketone antidepressant

Aminoketone antidepressant

Approved Uses

Contrave (naltrexone hydrochloride and bupropion hydrochloride) is indicated:

  • As an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of:

    • 30 kg/m2 or greater (obese)

    • 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbidity (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)

Wellbutrin SR (bupropion hydrochloride) is indicated:

  • For the treatment of major depressive disorder (MDD)

Dosage

  • Typically taken orally twice daily

  • Comes as 8 mg/90 mg extended-release tablets

  • Typically taken orally twice daily

  • Comes in 100 mg, 150 mg, and 200 mg tablets

Known Common Side Effects

Most common adverse reactions (greater than or equal to 5%):

  • Nausea

  • Constipation

  • Headache

  • Vomiting

  • Dizziness

  • Insomnia

  • Dry mouth

  • Diarrhea

Most common adverse reactions (incidence ≥5% and ≥2% more than placebo rate) are:

  • Headache

  • Dry mouth

  • Nausea

  • Insomnia

  • Dizziness

  • Inflammation of the throat

  • Constipation

  • Agitation

  • Anxiety

  • Abdominal pain

  • Ringing in the ears

  • Tremor

  • Fluttering heartbeat

  • Muscle pain

  • Sweating

  • Rash

  • Anorexia

Interactions & Contraindications

  • Uncontrolled hypertension

  • Seizure disorders, anorexia nervosa or bulimia, or undergoing abrupt discontinuation of alcohol, benzodiazepines, barbiturates, and antiepileptic drugs

  • Use of other bupropion-containing products

  • Chronic opioid use

  • During or within 14 days of taking monoamine oxidase inhibitors (MAOI)

  • Known allergy to any of the ingredients in Contrave

  • Drug interactions: MAOIs, antidepressants (e.g., selective serotonin reuptake inhibitors and many tricyclics), antipsychotics (e.g., haloperidol, risperidone, and thioridazine), beta-blockers (e.g., metoprolol), type 1C antiarrhythmics (e.g., propafenone and flecainide), digoxin, CYP2B6 inhibitors (e.g., ticlopidine or clopidogrel), CYP2B6 inducers (e.g., ritonavir, lopinavir, efavirenz, carbamazepine, phenobarbital, and phenytoin), drugs that lower seizure threshold, dopaminergic drugs (levodopa and amantadine)

  • Seizure disorder

  • Current or prior diagnosis of bulimia or anorexia nervosa

  • Abrupt discontinuation of alcohol, benzodiazepines, barbiturates, antiepileptic drugs

  • Monoamine oxidase inhibitors (MAOIs)

  • Known hypersensitivity to bupropion or other ingredients of Wellbutrin SR.

  • Drug interactions: CYP2B6 inducers, drugs metabolized by CYP2D6, digoxin, drugs that lower seizure threshold, dopaminergic drugs (levodopa and amantadine), MAOIs

  • Drug-laboratory test interactions: Wellbutrin SR can cause false-positive urine test results for amphetamines

Warnings & Precautions

  • Suicidal behavior and ideation

  • Neuropsychiatric adverse events during smoking cessation

  • Risk of seizure may be minimized by adhering to the recommended dosing schedule and avoiding coadministration with high-fat meal

  • Increase in blood pressure and heart rate

  • Liver toxicity

  • Angle-closure glaucoma

  • Use of antidiabetic medications: Weight loss may cause hypoglycemia

  • Pregnancy: Weight loss during pregnancy may cause fetal harm. Discontinue when a pregnancy is recognized

  • Neuropsychiatric adverse events during smoking cessation

  • Seizure risk

  • High blood pressure

  • Activation of mania/hypomania

  • Psychosis and other neuropsychiatric reactions

  • Angle-closure glaucoma

Boxed Warning

WARNING: SUICIDAL THOUGHTS AND BEHAVIORS

Increased risk of suicidal thinking and behavior in children, adolescents, and young adults taking antidepressants for major depressive disorder and other psychiatric disorders. Monitor for worsening and emergence of suicidal thoughts and behaviors.

Contrave has not been studied in pediatric patients.

WARNING: SUICIDAL THOUGHTS AND BEHAVIORS

Increased risk of suicidal thinking and behavior in children, adolescents and young adults taking antidepressants.

Monitor for worsening and emergence of suicidal thoughts and behaviors.

References

*This information is from the label for brand name Contrave®. See the Full Prescribing Information for more complete information. Naltrexone and bupropion, the active ingredients in Contrave, may also be the active ingredients in other medications, and this information may not be accurate for all medications that include the active ingredients naltrexone and bupropion.

*This information is from the label for brand name Wellbutrin SR®. See the Full Prescribing Information for more complete information. Bupropion, the active ingredient in Wellbutrin XL, may also be the active ingredient in other medications, and this information may not be accurate for all medications that include the active ingredient bupropion.

The information provided here is NOT MEDICAL ADVICE and is for informational and educational purposes only. The drug comparison tool does not determine eligibility for medications or treatments provided via the Hims/Hers platform. Consultation with a healthcare provider is required to assess suitability for any medical treatment based on individual health and medical history. All product names and associated trademarks are the property of their respective owners.

Related Articles

Find your medication kit

Prescription ingredients for personalized care